SDC4 and colonic neoplasm: Interestingly, hetero-oligomerization with syndecan-2 reduces both syndecan-4-dependent PKCα activation and cell adhesion and syndecan-2-mediated migration and anchorage-independent growth in colon cancer cells, suggesting a functional interplay of syndecans in tumor progression [71].